Overview

Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis

Status:
RECRUITING
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
This is a Phase 3 clinical study to evaluate the efficacy, safety, and tolerability of boric acid 600 mg vaginal inserts in patients with VVC.
Phase:
PHASE3
Details
Lead Sponsor:
pH-D Feminine Health LLC
Treatments:
boric acid